{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2537, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/7U9nPo_pdtDRnfRcKS_KfFgdncMmYqKCOld1mg91wtw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYjU2NTFlYWZhYTIzNjkwOGI1YWFlZWE1ZmRjMmRjYy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/1", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/0Th9PckCpT7BNffQHBiAtEZ2wza01VwUhhqbLeSVdrw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYjU2NTFlYWZhYTIzNjkwOGI1YWFlZWE1ZmRjMmRjYy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/1GkhggiYZwYFn4eUFd2znaQ_J19_jFy6ySn8yApyzO0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYjU2NTFlYWZhYTIzNjkwOGI1YWFlZWE1ZmRjMmRjYy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/1UZz1-8W4HB8RFJEzx_zTMt6hwUO0CE9ogGGSt5cEGg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYjU2NTFlYWZhYTIzNjkwOGI1YWFlZWE1ZmRjMmRjYy9wMDAxLnBuZw" }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/2", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a 3-column layout to map programs to their respective 2020 momentum/milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/3", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a process-oriented chevron diagram to map strategic pillars to specific risk mitigation areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/4", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a Gantt-style visualization to represent clinical and preclinical development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/5", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "Includes regulatory status callout.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/6", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "fadb3599-c931-4a6d-a063-50289cfaf55a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slide 6 presents the solution, Pegzilarginase", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a structured table format to define the disease context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/7", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 7, "beatId": "e99f4408-0f32-44f4-a5fa-b72cbd24841f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 7-8 present the problem statement for Arginase 1 Deficiency", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a visual demonstration of spastic diplegia in a patient.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/8", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 7, "beatId": "e99f4408-0f32-44f4-a5fa-b72cbd24841f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 7-8 present the problem statement for Arginase 1 Deficiency", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes clinical trial data (101A/102A) and baseline demographics for n=16 patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/9", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "The chart shows a box plot progression from baseline to week 56, demonstrating efficacy in reaching target ranges.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/10", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a color-coded heatmap to visualize patient improvement against baseline deficits.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/11", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "present_framework", "notes": "The slide outlines a strategic approach to trial design using four key pillars: Disease Burden, Known Impact, Look A-Like Condition, and Patient Feedback.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/12", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the clinical trial phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/13", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a geographic map to visualize addressable market segments based on genetic prevalence data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/14", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 14, "beatId": "1b5c0a8e-c983-4b60-94cb-869cca704402", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 14 presents market sizing data for ARG1-D patients", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "go_to_market", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/15", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/16", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/17", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a structured table format to define the clinical problem space.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/18", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a structured list format to contrast current care with its inadequacies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/19", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a Kaplan-Meier survival curve and a comparative table to illustrate the severity of the disease.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/20", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-20", "loopMatches": [ { "to": 21, "from": 20, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "27135307-336f-47bb-8e99-a1794510d33f", "evidence": "Slides 20-21 present the increased mortality and severe complication risk in patients with Homocystinuria", "position": 0, "objective": "Highlighting the consequences of not addressing Homocystinuria", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "solution", "function": "present_solution", "notes": "The chart is a Kaplan-Meier survival curve showing significant improvement over the PBS negative control.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/21", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-21", "loopMatches": [ { "to": 21, "from": 20, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "27135307-336f-47bb-8e99-a1794510d33f", "evidence": "Slides 20-21 present the increased mortality and severe complication risk in patients with Homocystinuria", "position": 0, "objective": "Highlighting the consequences of not addressing Homocystinuria", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a sequential cohort design for a clinical trial, moving from IV to SC administration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/22", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/23", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a simple table-like structure to define the problem space for a specific drug program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/24", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "pain_points", "function": "frame_problem", "notes": "Includes medical imagery of kidney stones to illustrate the problem.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/25", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "solution", "function": "present_solution", "notes": "Includes a before/after microscopy image showing crystal clearance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/26", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/27", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3a76-76eb-bdcd-70a194f2629a", "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/28", "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a", "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/tE-B7reIaHkySjUH_LwkhLcRiJlSCIg-9V5Y4EtnWFs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTg2YzRhM2JmNTA5YWVhMjFmMjRlMjE1OTg5MGNiNi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/1", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "3f302383-efe4-4c44-9d20-f8e4f342005f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with an overview of Q2 2020 highlights and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/irIlA2BQ6htR4WdGSkEEFVioXubRJX4MmWN-QfH_bgY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTg2YzRhM2JmNTA5YWVhMjFmMjRlMjE1OTg5MGNiNi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/TG_EQLCR5TbTACXcPkGhexLBrge1cu7cmDw_NEoM2-w/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTg2YzRhM2JmNTA5YWVhMjFmMjRlMjE1OTg5MGNiNi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Wvlh803-XzCK2tnetLLqtQLagxFIsXnwZPBChSpbIbc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTg2YzRhM2JmNTA5YWVhMjFmMjRlMjE1OTg5MGNiNi9wMDAxLnBuZw" }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/2", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "3f302383-efe4-4c44-9d20-f8e4f342005f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with an overview of Q2 2020 highlights and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/3", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "3f302383-efe4-4c44-9d20-f8e4f342005f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with an overview of Q2 2020 highlights and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/4", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "3f302383-efe4-4c44-9d20-f8e4f342005f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with an overview of Q2 2020 highlights and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/5", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "3f302383-efe4-4c44-9d20-f8e4f342005f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with an overview of Q2 2020 highlights and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "other", "function": "other", "notes": "The slide uses a two-tier structure to categorize partnerships by development stage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/6", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-6", "loopMatches": [ { "to": 10, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "558811c9-2680-40b0-851c-c38adb20b5e2", "evidence": "The presentation highlights the company's focus on immunotherapy and COVID-19 vaccine development", "position": 0, "objective": "What are the key areas of focus for BioNTech's pipeline?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "d225e240-012c-43ec-9ad8-8849e22c98f8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights the potential for multiple blockbuster opportunities and the need for innovative solutions", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram to illustrate the central strategy of 'Targeting Cancer + Immunomodulation' supported by five distinct therapeutic platforms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/7", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-7", "loopMatches": [ { "to": 10, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "558811c9-2680-40b0-851c-c38adb20b5e2", "evidence": "The presentation highlights the company's focus on immunotherapy and COVID-19 vaccine development", "position": 0, "objective": "What are the key areas of focus for BioNTech's pipeline?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "d225e240-012c-43ec-9ad8-8849e22c98f8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights the potential for multiple blockbuster opportunities and the need for innovative solutions", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/8", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-8", "loopMatches": [ { "to": 10, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "558811c9-2680-40b0-851c-c38adb20b5e2", "evidence": "The presentation highlights the company's focus on immunotherapy and COVID-19 vaccine development", "position": 0, "objective": "What are the key areas of focus for BioNTech's pipeline?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "d225e240-012c-43ec-9ad8-8849e22c98f8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights the potential for multiple blockbuster opportunities and the need for innovative solutions", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "roadmap", "function": "present_solution", "notes": "The slide uses a Gantt-style visualization for clinical trial phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/9", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-9", "loopMatches": [ { "to": 10, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "558811c9-2680-40b0-851c-c38adb20b5e2", "evidence": "The presentation highlights the company's focus on immunotherapy and COVID-19 vaccine development", "position": 0, "objective": "What are the key areas of focus for BioNTech's pipeline?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "d225e240-012c-43ec-9ad8-8849e22c98f8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights the potential for multiple blockbuster opportunities and the need for innovative solutions", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/10", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-10", "loopMatches": [ { "to": 10, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "558811c9-2680-40b0-851c-c38adb20b5e2", "evidence": "The presentation highlights the company's focus on immunotherapy and COVID-19 vaccine development", "position": 0, "objective": "What are the key areas of focus for BioNTech's pipeline?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "d225e240-012c-43ec-9ad8-8849e22c98f8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights the potential for multiple blockbuster opportunities and the need for innovative solutions", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Slide highlights key findings from a Nature publication regarding BNT111 vaccine efficacy and mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/11", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-11", "loopMatches": [ { "to": 15, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9d8a011b-49af-405a-9073-8a77c7487ff0", "evidence": "The presentation implies that not investing in innovative solutions could lead to missed opportunities", "position": 1, "objective": "What are the potential consequences of not investing in innovative solutions?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes process flow diagram, flow cytometry plots, and a scatter plot showing TCR frequency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/12", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-12", "loopMatches": [ { "to": 15, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9d8a011b-49af-405a-9073-8a77c7487ff0", "evidence": "The presentation implies that not investing in innovative solutions could lead to missed opportunities", "position": 1, "objective": "What are the potential consequences of not investing in innovative solutions?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "present_framework", "notes": "The slide uses a matrix-like structure to compare three clinical trial programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/13", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-13", "loopMatches": [ { "to": 15, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9d8a011b-49af-405a-9073-8a77c7487ff0", "evidence": "The presentation implies that not investing in innovative solutions could lead to missed opportunities", "position": 1, "objective": "What are the potential consequences of not investing in innovative solutions?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "other", "function": "present_solution", "notes": "The slide uses a visual representation of bispecific antibodies to explain their dual-target mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/14", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-14", "loopMatches": [ { "to": 15, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9d8a011b-49af-405a-9073-8a77c7487ff0", "evidence": "The presentation implies that not investing in innovative solutions could lead to missed opportunities", "position": 1, "objective": "What are the potential consequences of not investing in innovative solutions?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "present_solution", "notes": "Slide 15 of a BioNTech presentation, referencing SITC 2018.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/15", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-15", "loopMatches": [ { "to": 15, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9d8a011b-49af-405a-9073-8a77c7487ff0", "evidence": "The presentation implies that not investing in innovative solutions could lead to missed opportunities", "position": 1, "objective": "What are the potential consequences of not investing in innovative solutions?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "other", "function": "illustrate_case", "notes": "FIH = First-in-human; CPI = Checkpoint Inhibitor; ES-SCLC = Extensive-stage small cell lung cancer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/16", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/17", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a linear process flow to illustrate the rapid development timeline of the BNT162 vaccine program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/18", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "present_solution", "notes": "The slide highlights BNT162b2 in a table and shows the SARS-COV-2 spike protein structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/19", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a bulleted list structure to justify a strategic decision in a clinical development program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/20", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides updates on the company's pipeline and progress in various trials", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "other", "function": "present_framework", "notes": "The slide outlines the clinical trial protocol for the Pfizer-BioNTech COVID-19 vaccine.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/21", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "e917a87d-2b75-411a-b926-1b30683902ca", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an outlook for 2H 2020 and a Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "other", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/22", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "e917a87d-2b75-411a-b926-1b30683902ca", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an outlook for 2H 2020 and a Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes specific manufacturing site counts and dose targets for 2020/2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/23", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "e917a87d-2b75-411a-b926-1b30683902ca", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an outlook for 2H 2020 and a Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-3b27-7318-9c92-a5817b78bd41", "docSlug": "ce86c4a3bf509aea21f24e2159890cb6", "documentTitle": "BioNTech | Results Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2020-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/24", "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41", "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "e917a87d-2b75-411a-b926-1b30683902ca", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an outlook for 2H 2020 and a Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes guidance ranges for Q2 2020 estimates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/41", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a chevron graphic to visually separate historical data from future targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/42", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/43", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/44", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "traction", "function": "analyze_data", "notes": "The R&D bars are stacked to show the split between R&D and Capitalized Software.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/45", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/46", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table shows adjustments for D&A, interest, taxes, severance, and stock-based compensation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/47", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-39e0-7448-be58-f31157dba17d", "docSlug": "589feb1254413c82f4e2f28ba7e4fd22", "documentTitle": "Vertex | IPO Presentation Deck | 48 slides", "authorId": "vertex", "authorName": "Vertex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-39e0-7448-be58-f31157dba17d/48", "deckHref": "/decks/019de070-39e0-7448-be58-f31157dba17d", "deckAnchorHref": "/decks/019de070-39e0-7448-be58-f31157dba17d#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }